News

If you've watched The Handmaid’s Tale, you'll know that the show has no shortage of disturbing characters - from Commander ...
Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company ...
The Handmaid’s Tale has introduced its fair share of unsettling figures over the years, but none have shaken things up quite ...
Buying $1000 In GILD: If an investor had bought $1000 of GILD stock 20 years ago, it would be worth $9,708.95 today based on a price of $111.70 for GILD at the time of writing.
As Gilead Sciences gets underway with the key launch of its twice-yearly pre-exposure prophylaxis (PrEP) HIV med, the company ...
But after the rather open-ended Handmaid’s Tale  series finale in May, we have questions that still need answers. The Testaments follows three protagonists: Aunt Lydia (Ann Dowd), Agnes/Hannah (Chase ...
The July 24 event aims to inspire accessible and impactful philanthropy by breaking down barriers to meaningful change.
Drugs to prevent HIV transmission, known as pre-exposure prophylaxis or PrEP, have existed for more than a decade. But ...
Baltimore's beloved live music tradition, Jazzy Summer Nights is well into its 25th and final season. This farewell season, ...
This article discusses the DOJ’s growing crackdown on healthcare fraud, focusing on illegal speaker programs like Gilead’s $202 million settlement. It stresses the importance of strong compliance, ...